Fig_3.tif (625.87 kB)

Kaplan-Meier survival curves during the 3-year follow-up period.

figure

posted on 2015-06-22, 03:43 authored by Yin Li, Ke Pan, Li-zhi Liu, Yong-qiang Li, Mo-fa Gu, Hua Zhang, Wei-xi Shen, Jian-chuan Xia, Jian-jun Li

Both progression free survival (PFS) (A) and overall survival (B) were better in Arm 1 (GC+CIK group, n = 112) than in Arm 2 (GC chemotherapy alone group, n = 110).

History

Usage metrics

Read the peer-reviewed publication

Sequential Cytokine-Induced Killer Cell Immunotherapy Enhances the Efficacy of the Gemcitabine Plus Cisplatin Chemotherapy Regimen for Metastatic Nasopharyngeal Carcinoma

PLOS ONE

Keywords

metastatic nasopharyngeal carcinoma os sequential CIK treatment GC chemotherapy Gemcitabine Plus Cisplatin Chemotherapy Regimen efficacy metastatic NPC patients pfs

Licence

CC BY 4.0